Coronary Angioplasty/Stents for Cardiac Allograft Vasculopathy Does Not Alter Outcome for Heart Transplant Patients with ISHLT CAV2 or CAV3 Disease

被引：0
|
作者：
Patel, J. [1 ]
Azarbal, B. [1 ]
Kittleson, M. [1 ]
Kawano, M. [1 ]
Goldstein, Z. [1 ]
Rafiei, M. [1 ]
Moradzadeh, A. [1 ]
Czer, L. [1 ]
Kass, R. [1 ]
Kobashigawa, J. [1 ]
机构：
[1] Cedars Sinai Heart Inst, Los Angeles, CA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2011年 / 30卷 / 04期
关键词：
D O I：
10.1016/j.healun.2011.01.018
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11
引用
收藏
页码：S11 / S12
页数：2
相关论文
共 16 条
  • [11] The non-invasive doppler derived tei-index may differentiate between patients with and without coronary allograft vasculopathy (CAV) in pediatric heart transplant recipients
    Schubert, S.
    Lebkmkuhl, H. B.
    El Rabman, M. Abd
    Abdul-Khaliq, H.
    Meyer, R.
    Hiemann, N.
    Helzer, R.
    Berger, F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S238 - S239
  • [12] Increased Heart Rate After Heart Transplant Is Not Associated with Early Progression of Cardiac Allograft Vasculopathy (CAV) - A Prospective Study Using Highly Automatic Coronary Optical Coherence Tomography Segmentation Software in 3D
    Pazdernik, M.
    Kovarnik, T.
    Chen, Z.
    Wahle, A.
    Karmazin, V.
    Melenovsky, V.
    Kautzner, J.
    Tomasek, A.
    Bedanova, H.
    Sonka, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S297 - S298
  • [13] COMPARISON OF PURE ANTIBODY-MEDIATED REJECTION (AMR) WITH MIXED CELLULAR AND AMR IN REGARDS TO THE DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) AND CARDIOVASCULAR MORTALITY (CVM) IN HEART TRANSPLANT PATIENTS
    Ozdemir, B. Handan
    Ayva, Sebnem
    Terzi, Aysen
    Sade, L. Elif
    Basturk, Bilkay
    Sezgin, Atilla
    TRANSPLANT INTERNATIONAL, 2019, 32 : 213 - 213
  • [14] Quantitative 3D Analysis of Coronary Wall Morphology in Heart Transplant Patients: OCT-Assessed Cardiac Allograft Vasculopathy Progression
    Chen, Zhi
    Pazdernik, Michal
    Zhang, Honghai
    Wahle, Andreas
    Guo, Zhihui
    Bedanova, Helena
    Kautzner, Josef
    Melenovsky, Vojtech
    Kovarnik, Tomas
    Sonka, Milan
    MEDICAL IMAGE ANALYSIS, 2018, 50 : 95 - 105
  • [15] COMPARISON OF PURE ANTIBODY-MEDIATED REJECTION WITH MIXED CELLULAR AND ANTIBODY-MEDIATED REJECTION IN REGARDS TO THE PATHOLOGICAL FEATURES, DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) AND CARDIOVASCULAR MORTALITY (CVM) IN HEART TRANSPLANT PATIENTS
    Ozdemir, B. Handan
    Terzi, Aysen
    Ayva, Sebnem
    Sade, L. Elif
    Basturk, Bilkay
    Sezgin, Atilla
    TRANSPLANTATION, 2020, 104 (09) : S91 - S91
  • [16] Beyond Acute Rejection Screening Following Pediatric Heart Transplant: In Patients Negative for Rejection, Elevated Donor-Derived Cell-Free DNA is Associated with Cardiac Allograft Vasculopathy (CAV) and Donor Specific Antibodies (DSA)
    Olsen, Benjamin
    Cole, Jason
    Auerbach, Scott
    Simpson, Kathleen
    Everitt, Melanie
    CIRCULATION, 2024, 150
12